Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radius Fractures | 1 | 2026 | 26 | 0.920 |
Why?
|
| Arthrometry, Articular | 1 | 2018 | 2 | 0.570 |
Why?
|
| Wrist Joint | 1 | 2018 | 26 | 0.550 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 115 | 0.540 |
Why?
|
| Smartphone | 1 | 2018 | 75 | 0.520 |
Why?
|
| Mobile Applications | 1 | 2018 | 140 | 0.480 |
Why?
|
| Osteolysis | 1 | 2010 | 19 | 0.330 |
Why?
|
| Boronic Acids | 1 | 2010 | 28 | 0.320 |
Why?
|
| Pyrazines | 1 | 2010 | 35 | 0.320 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 106 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 586 | 0.260 |
Why?
|
| Accidental Falls | 1 | 2026 | 130 | 0.220 |
Why?
|
| Radiography | 1 | 2026 | 558 | 0.210 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1231 | 0.170 |
Why?
|
| Pronation | 1 | 2018 | 4 | 0.140 |
Why?
|
| Supination | 1 | 2018 | 6 | 0.140 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 72 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2010 | 324 | 0.120 |
Why?
|
| Aged | 2 | 2026 | 15049 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2026 | 5642 | 0.120 |
Why?
|
| Risk Factors | 1 | 2026 | 5458 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 687 | 0.110 |
Why?
|
| Calcitriol | 2 | 2005 | 25 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 129 | 0.110 |
Why?
|
| Female | 4 | 2026 | 34188 | 0.100 |
Why?
|
| Osteoblasts | 3 | 2011 | 204 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2015 | 133 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2026 | 6927 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 128 | 0.100 |
Why?
|
| Male | 5 | 2026 | 31180 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2018 | 2632 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 1631 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 354 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2011 | 20 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2721 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 35 | 0.080 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2011 | 142 | 0.080 |
Why?
|
| Bortezomib | 1 | 2010 | 59 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 102 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2011 | 154 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 203 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 223 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 196 | 0.080 |
Why?
|
| Mice, SCID | 1 | 2010 | 518 | 0.070 |
Why?
|
| Stem Cells | 1 | 2011 | 276 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 231 | 0.070 |
Why?
|
| Humans | 4 | 2026 | 65455 | 0.070 |
Why?
|
| Young Adult | 1 | 2018 | 4833 | 0.070 |
Why?
|
| Bone and Bones | 2 | 2005 | 152 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1567 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 642 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2005 | 77 | 0.050 |
Why?
|
| Phosphates | 1 | 2005 | 104 | 0.050 |
Why?
|
| Adenine | 1 | 2004 | 48 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 196 | 0.050 |
Why?
|
| Mice | 4 | 2011 | 11137 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 672 | 0.050 |
Why?
|
| Adult | 1 | 2018 | 17456 | 0.040 |
Why?
|
| Middle Aged | 1 | 2018 | 18384 | 0.040 |
Why?
|
| Animals | 4 | 2011 | 21380 | 0.040 |
Why?
|
| Proteins | 1 | 2004 | 764 | 0.040 |
Why?
|
| Pathology, Surgical | 1 | 2015 | 12 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 61 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 198 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 513 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 589 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1021 | 0.020 |
Why?
|
| Bone Diseases, Developmental | 1 | 2011 | 7 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2011 | 20 | 0.020 |
Why?
|
| Bone Regeneration | 1 | 2011 | 14 | 0.020 |
Why?
|
| Rats | 2 | 2005 | 1996 | 0.020 |
Why?
|
| Cell Line | 2 | 2005 | 2024 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1290 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2005 | 3488 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2005 | 11 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2005 | 22 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2005 | 82 | 0.010 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2004 | 2 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2004 | 56 | 0.010 |
Why?
|
| Poly A | 1 | 2004 | 29 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 56 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 152 | 0.010 |
Why?
|
| Sarcoma | 1 | 2004 | 36 | 0.010 |
Why?
|
| Hormones | 1 | 2004 | 62 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 376 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2004 | 267 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 542 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 414 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 611 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 312 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 454 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 700 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 916 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 1331 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1979 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 631 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 907 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 852 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1575 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 3774 | 0.010 |
Why?
|